Ceftin (cefuroxime) for Lyme disease

July 1997

    Glaxo is now promoting Ceftin (cefuroxime) for Lyme disease. It's the first antibiotic to be officially approved for this use.

    It's for patients with symptoms of EARLY Lyme disease...usually a rash and flu-like symptoms. These symptoms usually show up BEFORE antibodies are detectable on blood tests.

    Prompt treatment usually prevents long-term complications.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote